[{"id":"a89145ed-d1fb-47bb-8570-547616d247d2","acronym":"","url":"https://clinicaltrials.gov/study/NCT05275478","created_at":"2022-03-11T15:53:41.554Z","updated_at":"2024-07-02T16:34:59.862Z","phase":"Phase 1/2","brief_title":"Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors","source_id_and_acronym":"NCT05275478","lead_sponsor":"Tango Therapeutics, Inc.","biomarkers":" MTAP","pipe":" | ","alterations":" MTAP deletion","tags":["MTAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MTAP deletion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TNG908"],"overall_status":"Recruiting","enrollment":" Enrollment 192","initiation":"Initiation: 03/23/2022","start_date":" 03/23/2022","primary_txt":" Primary completion: 04/01/2025","primary_completion_date":" 04/01/2025","study_txt":" Completion: 09/01/2025","study_completion_date":" 09/01/2025","last_update_posted":"2024-05-31"}]